Cargando…
Pre-quitting nicotine replacement therapy: Findings from a pilot study
BACKGROUND: Using nicotine replacement therapy (NRT) while still smoking in the lead up to quitting could enhance success at quitting, one of the most cost-effective means of improving health, but little is known about its acceptability and tolerability. AIM: To test the acceptability and tolerabili...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633370/ https://www.ncbi.nlm.nih.gov/pubmed/19570295 http://dx.doi.org/10.1186/1617-9625-3-2-35 |
_version_ | 1782164112925523968 |
---|---|
author | Bullen, Chris Whittaker, Robyn Walker, Natalie Wallace-Bell, Mark |
author_facet | Bullen, Chris Whittaker, Robyn Walker, Natalie Wallace-Bell, Mark |
author_sort | Bullen, Chris |
collection | PubMed |
description | BACKGROUND: Using nicotine replacement therapy (NRT) while still smoking in the lead up to quitting could enhance success at quitting, one of the most cost-effective means of improving health, but little is known about its acceptability and tolerability. AIM: To test the acceptability and tolerability of using NRT while smoking for two weeks before quitting, to inform a randomised controlled trial of pre-quitting NRT versus usual NRT-based quitting practice. METHODS: Prospective pragmatic uncontrolled clinic-based pilot study in which 14 adult smokers recruited from a smoking cessation clinic were prescribed nicotine patches or gum with follow up for two weeks. Data were collected on participants' concerns about smoking while using NRT, importance of quitting, urges to smoke, smoking behaviour, previous NRT use and the length of the pre-quitting period. Urine tests were collected weekly for cotinine, and participants recorded smoking activity and noted experiences and changes in their health in diaries. RESULTS: Only 21% of 14 participants expressed concerns about using NRT while smoking. All of the nine followed up used it as recommended, 56% of these reporting no unpleasant symptoms. Median urine cotinine levels declined over the two weeks. Urges to smoke averaged 1.8 on a 4-point scale. All participants decreased the number of cigarettes per day. Diary records showed wide variation in smoking and NRT use, with an increased sense of control and determination to quit. CONCLUSION: Smokers using pre-quitting NRT over two weeks appeared to titrate nicotine levels and symptoms of toxicity were uncommon and of low intensity. |
format | Text |
id | pubmed-2633370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26333702009-01-31 Pre-quitting nicotine replacement therapy: Findings from a pilot study Bullen, Chris Whittaker, Robyn Walker, Natalie Wallace-Bell, Mark Tob Induc Dis Review BACKGROUND: Using nicotine replacement therapy (NRT) while still smoking in the lead up to quitting could enhance success at quitting, one of the most cost-effective means of improving health, but little is known about its acceptability and tolerability. AIM: To test the acceptability and tolerability of using NRT while smoking for two weeks before quitting, to inform a randomised controlled trial of pre-quitting NRT versus usual NRT-based quitting practice. METHODS: Prospective pragmatic uncontrolled clinic-based pilot study in which 14 adult smokers recruited from a smoking cessation clinic were prescribed nicotine patches or gum with follow up for two weeks. Data were collected on participants' concerns about smoking while using NRT, importance of quitting, urges to smoke, smoking behaviour, previous NRT use and the length of the pre-quitting period. Urine tests were collected weekly for cotinine, and participants recorded smoking activity and noted experiences and changes in their health in diaries. RESULTS: Only 21% of 14 participants expressed concerns about using NRT while smoking. All of the nine followed up used it as recommended, 56% of these reporting no unpleasant symptoms. Median urine cotinine levels declined over the two weeks. Urges to smoke averaged 1.8 on a 4-point scale. All participants decreased the number of cigarettes per day. Diary records showed wide variation in smoking and NRT use, with an increased sense of control and determination to quit. CONCLUSION: Smokers using pre-quitting NRT over two weeks appeared to titrate nicotine levels and symptoms of toxicity were uncommon and of low intensity. BioMed Central 2006-08-15 /pmc/articles/PMC2633370/ /pubmed/19570295 http://dx.doi.org/10.1186/1617-9625-3-2-35 Text en Copyright © 2006 Bullen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Bullen, Chris Whittaker, Robyn Walker, Natalie Wallace-Bell, Mark Pre-quitting nicotine replacement therapy: Findings from a pilot study |
title | Pre-quitting nicotine replacement therapy: Findings from a pilot study |
title_full | Pre-quitting nicotine replacement therapy: Findings from a pilot study |
title_fullStr | Pre-quitting nicotine replacement therapy: Findings from a pilot study |
title_full_unstemmed | Pre-quitting nicotine replacement therapy: Findings from a pilot study |
title_short | Pre-quitting nicotine replacement therapy: Findings from a pilot study |
title_sort | pre-quitting nicotine replacement therapy: findings from a pilot study |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633370/ https://www.ncbi.nlm.nih.gov/pubmed/19570295 http://dx.doi.org/10.1186/1617-9625-3-2-35 |
work_keys_str_mv | AT bullenchris prequittingnicotinereplacementtherapyfindingsfromapilotstudy AT whittakerrobyn prequittingnicotinereplacementtherapyfindingsfromapilotstudy AT walkernatalie prequittingnicotinereplacementtherapyfindingsfromapilotstudy AT wallacebellmark prequittingnicotinereplacementtherapyfindingsfromapilotstudy |